Clinical studies recruiting near Fitzroy

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
EARLY_Phase 1 · St Vincents Hospital, Melbourne · Radiopharm Theranostics, Ltd · NCT06824155 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · St. Vincent's Hospital Melbourne · Ichnos Sciences SA · NCT05862012 BMB-101 in Absence Epilepsy and DEE
Phase 2 · St Vincent's Hospital Melbourne · Bright Minds Biosciences Pty Ltd · NCT06401538 ROADMAP Clinical Trial
Phase 4 · St Vincents · University of Newcastle, Australia · NCT06771050 Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
Phase N/A · St Vincent's Hospital Melbourne · St Vincent's Hospital Melbourne · NCT05117723 Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · St Vincent's Hospital Melbourne · PYC Therapeutics · NCT06714006 Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Phase N/A · Department of Rheumatology, St Vincent's Hospital (Melbourne · Monash University · NCT03138941 Closed Loop and Education for Hypoglycemia Awareness Restoration
NA · University of Melbourne · Milton S. Hershey Medical Center · NCT06325202 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · St Vincents Hospital Melbourne - PPDS · Takeda · NCT05677971 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · St Vincent's Hospital (Melbourne) Ltd · Takeda · NCT06499285 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0365 · Bristol-Myers Squibb · NCT03899155 Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r
Phase 1 · St Vincent's Hospital Melbourne · Imugene Limited · NCT03666000 The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Phase N/A · St Vincent's Correctional Health Services · Kirby Institute · NCT05248555 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
EARLY_Phase 1 · St. Vincent Hospital · Ascentage Pharma Group Inc. · NCT03537482 HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Subo
NA · St Vincent's Hospital Melbourne · Concord Repatriation General Hospital · NCT04455932 Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Ca
Phase 3 · St. Vincent's Hospital · Vergent Bioscience, Inc. · NCT07499674 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · St Vincents Hospital Melbourne · Janssen Research & Development, LLC · NCT07258511 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · St Vincent's Hospital Melbourne /ID# 277002 · AbbVie · NCT07155187 A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Phase 1/Phase 2 · St Vincents Hospital Melbourne · BeOne Medicines · NCT05006716 Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
NA · St. Vincent's Hospital · iVEAcare · NCT07640191 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · St Vincent's Hospital Melbourne · Pfizer · NCT05623020 A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Phase 1 · St. Vincent's Hospital Melbourne · Umoja Biopharma · NCT06528301 A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monother
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT05714839 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · St Vincents Hospital Melbourne · BeOne Medicines · NCT06943872 AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06137144 FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Phase 2 · St Vincent's Hospital (Melbourne) · The George Institute · NCT06409364 The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid
NA · Bionics Institute · The Bionics Institute of Australia · NCT07017686

Look up another city

Look up another condition